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Abstract: A 59-year-old man presented with a skin eruption and bilateral swelling of the legs. Soon after the initial presentation, he 
developed acute respiratory distress syndrome (ARDS) with miliary lung nodules. Culture of samples from the skin ulcers, sputum, and 
bronchoalveolar lavage fluid all revealed Mycobacterium szulgai infection. The patient was successfully treated with antituberculosis 
drugs. M. szulgai infection is very rarely reported worldwide, and disseminated infection usually occurs in immunocompromised 
patients. However, the present patient was a non-immunocompromised case, although he was a hepatitis B virus carrier. While the 
  progression to ARDS from M. tuberculosis infection is well known, this is the first case of M. szulgai infection progressing to ARDS.
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Introduction
The  incidence  of  non-tuberculosis    mycobacterial 
(NTM)  infection  has  increased  recently,  and  this 
  condition  currently  accounts  for  10%–15%  of 
all    mycobacterial  infection  cases.1,2  While  the 
Mycobacterium avium complex (MAC) and M. kansasii 
are responsible for more than 90% of cases of myco-
bacterial infection, Mycobacterium species have diver-
sified and now include species such as M. szulgai.3 
M. szulgai is an uncommon mycobacterial pathogen 
in humans.4 It causes pulmonary disease resembling 
the common type of M. tuberculosis infection, as well 
as extrapulmonary infection.   Disseminated infection 
of M. szulgai is rare and usually occurs in immuno-
compromised patients.5
Here, we report an unusual case of   disseminated 
mycobacterial  infection  progressing  to  acute 
respiratory  distress  syndrome  (ARDS)  in  a  non-
  immunocompromised  hepatitis  B  virus  (HBV) 
carrier.
case Report
A  59-year-old  man  was  admitted  to  our  hospital 
because  he  was  experiencing  severe  respiratory 
distress.  He  had  been  diagnosed  with  intestinal 
catarrh when he was 1 year old, nephritic syndrome 
when he was 13 years old, and pleuritis when he 
was 57 years old. He was an HBV carrier, but not 
immunocompromised. He did not have a history of 
tuberculosis. He lived in a rural district composed 
mainly of paddy fields and worked as an engineer 
in  an  office.  He  was  an  ex-smoker,  having  quit 
smoking at the age of 30 years. Six months before 
hospital admission, he presented with edema of the left 
leg and low-grade fever. At the time of presentation, 
he tested positive for anti-Chlamydia pneumoniae 
immunoglobulin  antibodies  and  was  treated  with 
clarithromycin.  He  experienced  symptom  relief 
with this treatment within a few weeks. However, 
4 months before hospital admission, soon after the 
treatment  was  discontinued,  he  developed  low-
grade fever, a skin eruption resembling folliculitis 
in the left upper arm, and adenopathy of multiple 
lymph nodes. Two weeks before hospital admission, 
he presented with bilateral swelling of the fingers 
and feet (Fig. 1A). Further, the skin eruption had 
progressed  to  ulceration  (Fig.  1B).  Isolates  from 
the  ulcer  exudate  were  cultured  and  revealed 
cutaneous  infection  with  mycobacterial  species. 
He was therefore referred to our department. Chest 
X-ray (CXR) findings were normal, but computed 
tomography  (CT)  revealed  the  presence  of  tiny 
miliary nodules in both lung fields (Fig. 2A). Five 
days before admission, the patient developed a fever 
(temperature .38 °C). He was urged to admit himself 
to our hospital because of severe respiratory distress. 
Physical examination revealed tachypnea and 80% 
oxygen saturation in room air. Prominent inspiratory 
crackles  were  heard  over  both  lower  lung  fields. 
CXR showed diffuse bilateral infiltration (Fig. 3), 
and CT revealed the presence of multiple nodules 
and infiltrates in both lung fields (Fig. 2B). Blood 
gas analysis in room air revealed a partial pressure 
of oxygen in arterial blood (PaO2) of 46 mmHg and 
a pH of 7.46. The other blood parameters were as 
follows: hemoglobin level, 11.3 g/dL, was within 
normal limits; leukocyte count, 14.4 × 103 cells/L, 
was high; and C-reactive protein level, 20.8 mg/L, 
was high. The brain natriuretic peptide level was 
30.0 pg/mL, which was within the normal limits.
We  initiated  treatment  with  a  broad-spectrum 
panel of antimicrobial agents, namely, meropenem 
and  ciproxacin,  along  with  methylprednisolone 
pulse therapy. However, over the next 24 hours, the 
patient developed severe respiratory failure (PaO2/
fraction of inspired oxygen [PF ratio] ,200) and 
required  intubation  and  mechanical  ventilation 
with  positive  end-expiratory  pressure.  Intubation 
was followed by bronchoscopy with bronchoalve-
olar lavage (BAL). Positive results were obtained 
AB
Figure 1. (A) Swelling of the feet and (B) skin ulcer observed 2 weeks 
before hospital admission.Mycobacterium szulgai-induced acute respiratory distress syndrome
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in    Ziehl-Neelsen  staining  of  a  sputum  smear  and 
BAL fluid, but   negative results were obtained for 
Gram  staining.  We  therefore  strongly  suspected 
  mycobacterial infection. Although M. tuberculosis 
and the MAC were not detected in polymerase chain 
reaction analysis of the patient’s samples, we con-
tinued to suspect a miliary mycobacterial infection. 
  Therefore, we initiated treatment with a 4-drug regi-
men comprising rifampicin 450 mg/day,   isoniazid 
300  mg/day,  pyrazinamide  1500  mg/day,  and 
streptomycin 1 g/day. Meropenem and ciproxacin 
were  discontinued  17  days  after  hospital  admis-
sion because the patient’s condition improved. Skin 
biopsy which was done at 1 weak after admission 
revealed diffuse infiltration of mixed inflammatory 
cells in the dermis, which was consistent with the 
diagnosis  of  cutaneous  NTM  infection  (Fig.  4).6 
CXR  and  CT  revealed  a  gradual  improvement  in 
the patient’s condition, and the patient was weaned 
off  mechanical  ventilation  23  days  after  admis-
sion. About 1 month after admission, we identified 
M.   szulgai in cultures of the sputum, skin ulcer exu-
date, and BAL fluid using the colorimetric microdi-
lution plate hybridization method.7 About 2 months 
after admission, the bilateral infiltrates had almost 
completely disappeared from the lungs (Fig. 2C), 
and the patient was discharged.
Discussion
M. szulgai infection is very rare, and this bacterium 
accounts  for  ,0.5%  of  all  isolates  obtained  from 
human patients with NTM infection.8,9 In Japan, only 
27 cases of M. szulgai infection have been reported 
between 1989 and 2008, most of which involved pre-
existing disease.10 In a study in Turkey, mycobacterial 
growth was positive in 10041 of 45981 samples from 
19553  patients  with  a  prediagnosis  of  pulmonary 
A
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Figure 2. (A) Thoracic computed tomography (CT) obtained 2 weeks 
before  hospital  admission,  showing  tiny  nodules  with  no  abnormal 
  shadows. (B) CT scan obtained upon admission, showing shadows and 
nodules on both lung fields. (c) CT scan obtained shortly before dis-
charge from the hospital, showing almost complete disappearance of the 
shadows.
Figure  3.  posteroanterior  chest  radiograph  obtained  upon  hospital 
admission, showing diffuse bilateral infiltration.ohta et al
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tuberculosis  between  November  2004  and  January 
2009; M. szulgai was isolated from only 3 patients 
among this study population.11
Cultures yielding M. szulgai usually have a patho-
logic significance, because this bacterium is rarely 
recovered from the environment.8,9 Consequently, in 
appropriate clinical circumstances, 1 positive culture 
may suffice for diagnosing M. szulgai infection. In 
the present case, cultures of the skin ulcer exudate, 
sputum, and BAL fluid all revealed M. szulgai infec-
tion only, implicating this bacterium as the sole cause 
of the miliary infection.
The clinical features of this case, including the 
acute onset, bilateral shadows, low PF ratio (,200), 
and no clinical evidence of elevated left atrial pres-
sure, were compatible with the diagnostic criteria for 
ARDS.12 NTM infection-induced ARDS is very rare.13 
In  contrast,  miliary  tuberculosis  is  a  well-known 
cause of ARDS.14,15 This case is the first reported 
case of M. szulgai infection progressing to ARDS. 
Miliary tuberculosis accounts for 2.3% of all cases 
of  tuberculosis  infection  in  Japan.14    Additionally, 
in a series study in South Korea, only about 20% 
of miliary tuberculosis patients developed ARDS.16 
Thus,  miliary  infection-induced  ARDS  probably 
accounts for less than 1% of all tuberculosis cases. 
On the other hand, the incidence of miliary infection 
among all cases of M. szulgai infection cannot be 
easily estimated, because infection with M. szulgai 
is very rare.
In conclusion, M. szulgai can cause severe disease 
by hematogenous spread. M. szulgai infection-  induced 
ARDS  is  extremely  rare,  but  can  be  successfully 
treated with antituberculosis drugs.
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